Follow us on LinkedIn
España
NTC
Novelty, Technology, Care
News & Events
-
NTC and Aspen announce SAHPRA positive outcome for the fixed dose combination of levofloxacin and dexamethasone multidose eye drops- Nov 24, 2021
NTC granted the license and commercialisation rights of its patented… -
NTC and STADA announce commercial partnership for portfolio of ophthalmic products in the MENA region- Sep 07, 2021
NTC, international pharmaceutical company headquartered in Milan, Italy, and STADA,… -
NTC presents the Value report 2021 to its stakeholders- July 29, 2021
“Advanced scientific research and technology are the drivers of NTC’s… -
Innovation in ophtha made in Italy: NTC has developed the first combination of levofloxacin and dexamethasone eye drops- May 13, 2021
NTC, an Italian pharmaceutical company specializing in ophthalmology, has developed…
PHARMACOVIGILANCE